PharmaBiota Advanced Microbiota Drug Development Platform
August 16, 2022
Trademark Summary
The trademark application PharmaBiota Advanced Microbiota Drug Development Platform was filed by Microviable Therapeutics, a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on August 24, 2022, and it was registered by office on December 1, 2022 without any oppositions.
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Probiotic bacteria for the food industry
Probiotic bacterial cultures for the food industry
Antimicrobial preservatives for pharmaceuticals
Preservatives for maintaining the viability of micro-organisms in cultures [scientific]
Biological preparations for use in industry and science.
The mark was filed in class 5 with following description of goods:
Veterinary preparations for treatment of intestinal bacteria
Pharmaceutical preparations for the prevention of diseases caused by bacteria
Pharmaceutical preparations for the treatment of diseases caused by bacteria
Pharmaceutical preparations for the treatment of disorders caused by bacteria
Probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system
Prebiotic supplements
Probiotic supplements
Nutraceuticals for use as a dietary supplement
Probiotic bacterial formulations for veterinary use
Antibiotic dermatological products
Probiotic bacterial formulations for medical use
Antifungal medication
Anti-cancer drugs
Antibiotic food supplements for animals
Antibiotics
Allergy medication
Anti-infectives
Anti-oxidant food supplements
Medicines for alleviating constipation
Nutritive substances for microorganisms
Medicines for intestinal disorders
Biological preparations for the treatment of cancer
Biopharmaceuticals for the treatment of cancer
Anti-neoplastic preparations of microbial origin
Digestive enzymes
Pharmaceutical drugs
Medicine
Antitumor drugs
Drug delivery agents that facilitate the delivery of pharmaceutical preparations.
The mark was filed in class 42 with following description of goods:
Scientific services relating to the isolation and cultivation of human tissues and cells
Research and development in the field of microorganisms and cells
Biochemical research and development
Genetic research
Structural and functional analysis of genomes
Research in the field of gene therapy
Laboratory research in the field of gene expression
Analysis in the field of molecular biology
Research and development in the pharmaceutical and biotechnology fields
Research relating to biotechnology
Biotechnological research relating to agriculture
Information on the subject of scientific research in the field of biochemistry and biotechnology
Consultancy relating to biotechnology
Research and development in the field of biotechnology
Scientific research in the field of genetics and genetic engineering
Technological research
Research and development for the pharmaceutical industry